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Abstract: Protein-protein interfaces have crucial functions in many biological processes. The large
interaction areas of such interfaces show complex interaction motifs. Even more challenging is the
understanding of (multi)specificity in protein-protein binding. Many proteins can bind several partners to
mediate their function. A perfect paradigm to study such multispecific protein-protein interfaces are snake
venom metalloproteases (SVMPs). Inherently, they bind to a variety of basement membrane proteins of
capillaries, hydrolyze them, and induce profuse bleeding. However, despite having a high sequence
homology, some SVMPs show a strong hemorrhagic activity, while others are (almost) inactive. We present
computer simulations indicating that the activity to induce hemorrhage, and thus the capability to bind the
potential reaction partners, is related to the backbone flexibility in a certain surface region. A subtle interplay
between flexibility and rigidity of two loops seems to be the prerequisite for the proteins to carry out their
damaging function. Presumably, a significant alteration in the backbone dynamics makes the difference
between SVMPs that induce hemorrhage and the inactive ones.
Introduction
The ability of proteins to bind other biomolecules is crucial
for many biological processes in living organisms. Investigating
these interactions is a prerequisite for the design of new proteins
with defined activity and selectivity that could be used as
therapeutic agents as well as tools for cellular and molecular
research and engineering.1-6 Consequently, a comprehensive
knowledge of the relations between sequence, structure, and the
associated dynamics is necessary to understand their function
and to design novel functional proteins.7 However, there are
still significant limitations on this topic, because there is no
reasonable description of protein flexibility in most of the current
protein design approaches.1,8-18 It is generally accepted that
proteins are inherently flexible,19-27 and it has already been
shown that this dynamic behavior is fundamental to their
function.28-31
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In contrast to the historic “lock-key” model of Fischer,32
which assumes the binding process to be a static insertion of a
low-energy conformation of the ligand into a rigid binding site,
a large number of possible conformations of the receptor and
the binding proteins exists.33,34 Moreover, virtually all binding
processes go hand in hand with conformational changes. It is
supposed that conformations of the bound state are sampled in
the free state and conformations of the free state are accessible
in the bound state. Experimentally, evidence was found for
protein-substrate,35-40 protein-protein,21,41-45 and protein-
nucleic acid complexes.46-48 Consequently, proteins exist in a
multitude of conformations in solutions.49 This is the basis for
the binding mechanism model known as “conformational
selection”.50-52 In principle, the “conformational selection
model” assumes that a protein already exists in multiple
conformations, which represent its properties. A ligand chooses
its most favored preexisting protein conformation upon binding,
shifting the conformational ensemble of the receptor toward the
bound conformation.
An alternative model is the induced fit. In contrast to the
conformational selection, the conformation of the receptor in the
complex is not formed until binding. The ligand binds and
consequently induces conformational changes. However, even if
those two mechanisms seem to be mutually exclusive, it was shown
that the distinction is blurred.53 The maltose binding protein is good
evidence.54 Several ground-state conformations that are significantly
populated are “chosen” by ligands. However, the receptor confor-
mation is altered upon binding. The result is a mixture of induced
fit and conformational selection.
A fascinating feature of many important proteins is multi-
specificity. Many proteins do not have a single interaction
partner to mediate their function but instead can bind several
partners with good affinity.55,56 In terms of the “conformational
selection model”, this implies that the protein has a rugged
energy hypersurface with numerous minima.52 Every ligand
chooses it a favorable counterpart as binding partner from the
conformational ensemble of the receptor and binds to it.
For almost three decades, the hypothesis that structural ensembles
are useful representations of the structure-dynamics relationship
has been readily accepted.57 This was shown for protein-ligand
interactions,58 protein-protein docking59,60 and even protein
design.10,28,29,61-63 But it is very difficult to access such ensembles
by experimental methods. The most suitable experimental technique
is NMR, but even in this case, limitations in size and time resolution
hamper the generation of a representative ensemble. Due to the
comparably small size of SVMPs, NMR experiments could be
feasible. However, no such results are presented in the literature
so far. MD simulations offer a more viable approach. Starting from
an X-ray structure, the time evolution of the system is observed,
and thus an ensemble is generated.
Detailed analyses of unbound interfaces of protein-protein
interactions by computer simulations are rather rare. The only
analysis the authors are aware of was published by Gru¨nberg
et al.64 In this study, only entropy calculations but no structural
evaluations are presented. The main conclusion by Gru¨nberg
et al. is that protein-protein association does not lead to a
general loss of conformational entropy. Also, an elaborate
flexibility with complex (allosteric) rearrangements upon
protein-protein association was found. This indicates the high
complexity connected with protein-protein association.
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Specificity in Snake Venom Metalloproteases A R T I C L E S
For the investigation of multispecific protein-protein inter-
faces, snake venom metalloproteases (SVMPs) are excellent
prototypes provided by nature. Inherently, their function is to
hydrolyze a variety of extracellular matrix proteins, including
those of the basement membranes (BM) surrounding endothelial
cells in the microvasculature, thus inducing hemorrhage.65,66
This hemorrhagic activity can either occur locally at the site of
venom injection or systemically, affecting multiple organs.67
The mechanism by which viperid venoms induce hemorrhage
is dependent on the proteolytic degradation of components of
the BM in the wall of microvessels, especially capillaries.67,68
It has been hypothesized that in ViVo hemorrhage occurs by a
two-step mechanism: first, proteins of the BM and of the
endothelial cell membrane, involved in cell-BM adhesion, are
cleaved, which leads to the weakening of the mechanical
stability of capillaries; thereafter, in a second step, the hemo-
dynamic forces normally operating in the microcirculation, like
hydrostatic pressure and shear stress, contribute to the distension
and rupture of the capillary wall, with the ensuing extravasa-
tion.67 Thus, hydrolysis of BM components and its binding is
a key step in the pathogenesis of venom-induced hemorrhage.
Interestingly, however, SVMPs differ significantly in their
ability to induce hemorrhage. Despite having similar proteolytic
activity toward diverse substrates in Vitro, some of these
enzymes are hemorrhagic, whereas others are not.67,69 We
assume that there are structural determinants in the metallo-
proteinase domain that enable them to induce hemorrhage.
However, because no structures of protein-protein complexes
are available, the characterization of such structural features
remains elusive. Structural analyses of several hemorrhagic and
nonhemorrhagic SVMPs revealed small variations in a loop
region surrounding the active site.70 This variable region
contains about 25 amino acid residues and is interrupted by the
structurally conserved three residue motif (Cys-Ile/Val-Met) of
the Met-turn only.
Despite intensive investigations in this research area, the
detailed structural determinants of hemorrhagic activity remain
unknown, and there is still no possibility to predict the
hemorrhagic potential of SVMPs on the basis of structure or
sequence analysis. One study suggested a slight, but not linear,
correlation of polar molecular surface area characteristics and
hemorrhagic potential.71 In a recently solved complex structure
of BaP1, the first part of the above-mentioned loop region was
found to exist in two conformations. This finding led to the
assumption that flexibility of this loop could be responsible for
hemorrhagic activity.72
To investigate the dynamics in this region, we have analyzed
four different SVMPs with consistent activity data. They were
measured either in our own laboratory or with the same
experimental protocol.73-75 Two of them exert hemorrhagic
activity, while the other two do not induce this effect. The active
ones are BaP1 from Bothrops asper72 and acutolysin-A from
Agkistrodon acutus,76 and the inactive ones are leucurolysin-A
from Bothrops leucurus77 and H2-proteinase from Trimeresurus
flaVoViridis,78 respectively.
In a pairwise sequence alignment, BaP1 and leucurolysin-A
exhibit the same type of amino acid side chains in 78% of all
residues (Figure 1). Even more impressive is the fact that only
5% of all amino acid side chains are of different chemical
properties. Compared with H2-proteinase, the sequential similar-
ity of BaP1 is still rather high (53%), especially considering
that the similarity between both active and both inactive proteins
is equal (53%) and even lower (51%), respectively. Comparing
all four SVMPs, the only major difference in sequence occurs
at the loop region directly following the highly conserved active
site, which surrounds the so-called Met-turn (green shaded area
in Figure 1). Nevertheless, it is not possible to correlate the
amino acid composition directly to the activity behavior
(hemorrhagic actives and inactives) of the proteins. Indeed, there
are some remarkable similarities within the group of actives
and inactives. For example, the hemorrhagic active proteins
(BaP1 and acutolysin-A) both present a Gly-Ser-Cys-Ser-Cys-
Gly-Ala/Gly-Lys-Ser (residues 154-163) sequence in the part
before the Met-turn, whereas the inactives do not show any
identical residues in this section besides the two conserved
cysteinyl residues. This is a further hint that flexibility might
play a role to distinguish between active and inactive proteins,
bearing in mind that these amino acid side chains are known to
enable a broader main chain conformational flexibility.80,81 In
the part after the Met-turn (residues 167-177), no direct
correlation between sequence and activity can be observed.
Either active and inactive proteins possess the same amino acid
side chain (positions 167, 169-172, and 174-177) or, like at
position 173, they do not show the same properties within the
actives (Val and Glu) and the inactives (Lys and Gly). Therefore
and as mentioned above, sequence alignments can at most lead
to the localization of the potential interaction area but do not
explain in detail why some SVMPs are hemorrhagic active and
some are not.
Methods
The X-ray structures of BaP1 (PDB code: 2w15), acutolysin-A
(1bud), and H2-proteinase (1wni) were extracted from the Protein
Data Bank (PDB).82 The structure of leucurolysin-A is unreleased
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and was kindly provided by R. N. Ferreira and A. M. de Pimenta,
Universidade Federal de Minas Gerais, Brasil. These four proteins
were chosen because their activity was determined consistently with
the same experimental protocol.73–75 For BaP1, both conformations
of the 160-162 loop were used (referred as “BaP1 conformer 1”
and “BaP1 conformer 2” in the following, leading to a total of three
simulations for the hemorrhagic active proteins). BaP1 is ligated
with a peptidomimetic inhibitor in the proteolytic binding site. This
ligand is retained for the simulations.
Because the structure of leucurolysin-A contains several 1,2-
dihydroxyethane (in the following abbreviated with “edo”) mol-
ecules, which are crystallization agents, two simulations were set
up. One with edo molecules and another one without them. This
provides two independent starting points (referred as “leucurol-
ysin-A with edo” and “leucurolysin-A without edo” in the follow-
ing). Edo is consequently treated in the same way as the ligand in
BaP1.
The structures were imported into MOE 2010.0983 and proto-
nated with the protonate3D tool.84 Afterwards, the protonation state
of the amino acids, especially of the histidines, was revised
manually. This was especially necessary for the Zn2+ coordinating
histidines, because MOE proposed in some cases deprotonated
species, which were changed into neutral histidines coordinating
with the lone pair.
The structures were further prepared in the leap tool of
amber10.85 For the proteins, the amber force field 99SB86 was
employed. In BaP1, a nonstandard residue is present. This pyro-
glutamate unit was constructed from a glutamate and the atom types
were assigned manually. The partial charges were calculated with
RESP HF-6/31G* using antechamber85 and Gaussian 03.87 The
same procedure for partial charges and the amber generalized atom
force field (GAFF)88 were applied for the ligand in BaP1 and edo
in leucurolysin-A. For Zn2+ ion, the parameters according to Ryde89
were used. All water molecules present in the X-rays were retained.
The structures were then soaked in a box of TIP3P water molecules.
The equilibration for the MD simulation was carried out using
the sander tool of amber10. The protocol consists of 15 steps. All
minimizations comprised 2000 steps of steepest decent followed
by 2000 steps of conjugate gradient. Firstly only hydrogens were
minimized to gain a reasonable hydrogen bond network. Afterwards
a minimization of the water molecules was performed with a
positional restraint of 1000 kcal mol-1 Å-2 on the protein heavy
atoms. For the next three simulation steps, the restraint was kept
on the protein heavy atoms. Firstly the temperature was raised from
100 to 300 K over 100 ps in a NVT ensemble followed by 200 ps
simulation at 300 K with a NPT ensemble to adjust the box size.
Afterwards a cooling back to 100 K in a NVT ensemble was
performed. Then a series of nine minimizations with decreasing
positional restraint on the protein heavy atoms (1000, 500, 100,
50, 20, 10, 5, 2, 0 kcal mol-1 Å-2) was performed. Thus, steric
clashes and similar problems should be removed without signifi-
cantly disturbing the structure. Finally, the system was again heated
to the simulation temperature of 300 K over a 100 ps NVT
simulation.
Production runs were carried out with the pmemd tool of
amber10. All simulations were performed in a NPT ensemble with
a nonbonded cutoff of 8 Å, particle mesh ewald (PME with Amber
defaults values; ewald coefficient 0.34864 Å-1; cutoff 8 Å; tolerance(83) MOE (The Molecular Operating Environment), version 2010.01,
software available from Chemical Computing Group Inc., 1010
Sherbrooke Street West, Suite 910, Montreal, Canada H3A 2R7, http://
www.chemcomp.com, 2009.
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Figure 1. (a) Sequence alignment of the four SVMPs performed with ClustalW2.79 Residue numbering and secondary structure elements (blue, R-helices;
cyan, -sheets; pale blue, 310-helix) correspond to those of BaP1 (2w15). Highly conserved residues of the active site and the Met-turn are depicted in red
letters, and residues of the highly dynamic loop area are green shaded. The quantity of residues and sequence identities compared with BaP1 are given at
the end of the sequences. Pairwise alignments of the other three proteins resulted in following sequence identities: leucurolysin-A and H2-proteinase 53%;
leucurolysin-A and acutolysin-A 50%; H2-proteinase and acutolysin-A 51%. Consensus symbol definitions: “/” denotes identical residues; “:” conserved
residue substitution; “.” semiconserved residue substitution. (b) The hemorrhagic actives (BaP1 (green) and acutolysin-A (red)) and the inactives (H2-
proteinase (yellow) and leucurolysin-A (cyan)) show a high structural similarity. Differences arise from residues 156-175. (c) An enlarged depiction of the
residues 156-175. Structural deviations in the X-ray structures are not correlated with the hemorrhagic activity. All four protein structures show deviations
in the backbone structure of residues 156-175; however, no separation from actives (red and green) and inactives (cyan and yellow) by means of structural
analyses is possible.
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0.00001)90 for long-ranging electrostatics and SHAKE for the bonds
involving hydrogens. As a temperature regulation system, the
Langevin algorithm91 was applied (time constant 1.0 ps; the seed
for the pseudorandom number generator was set to 71277; collision
frequency, γ ) 3.0 ps-1).
Calculations of root-mean-square deviations (rmsd, positional
root-mean-square deviations of the CR atoms), B-factors, 2D-rmsd
plots (a rmsd value for the backbone of every snapshot compared
with every other snapshot is displayed as a heatmap), and
representative structures92 were done with ptraj. Representative
structures were calculated on 1200 snapshots, extracted every 25
ps, applying the means algorithm. B-factors were calculated as the
mean square positional fluctuations of an atom multiplied with (8/
3)π2.
Pictures of structures and structural analysis were performed in
PyMOL.93
Results
MD Simulations. After the equilibration, for all six complexes,
30 ns of MD simulation was performed. Stable trajectories with
mean backbone rmsd’s well below 2 Å could be generated for
further analysis (Figure 2).
Conformer 1 of BaP1 undergoes a conformational change in
two regions, which is connected with a larger rmsd shift (Figure
3).
Besides a transition in the loop of interest for the protein-
protein interface (residues 153-165; all residue numbers
mentioned in the following correspond to BaP1 (2W15); the
other proteins were aligned on BaP1 for analyses), also a region
from residue 59 to 70 rearranges itself. However, the latter loop
is on the opposite site of the protein and therefore should not
disturb the flexibility of the former loop. As Figure 3 illustrates,
the rest of the protein perfectly stays in its structural shape. A
similar event is not observed in any of the other simulations
(see Figure 2).
In comparison of the two conformations of BaP1, neither a
conversion from one conformation into the other nor a common
end point conformation is found. Both are rather stable during
the whole time of 30 ns of computer simulations.
(90) Darden, T.; York, D.; Pedersen, L. J. Chem. Phys. 1993, 98 (12),
10089–10092.
(91) Wu, X.; Brooks, B. R. Chem. Phys. Lett. 2003, 381 (3-4), 512–518.
(92) Shao, J.; Tanner, S. W.; Thompson, N.; Cheatham, T. E. J. Chem.
Theory Comput. 2007, 3 (6), 2312–2334.
(93) PyMOL; DeLano Scientific: Palo Alto, CA, 2002.
Figure 2. Two-dimensional rmsd plots for the CR atoms for (a) acutolysin-
A, (b) BaP1 comformer 2, (c) H2-proteinase, (d) leucurolysin-A with edo,
and (e) leucurolysin-A without edo. Only in the BaP1 conformer 1
simulation a conformational change occurs (see Figure 3).
Figure 3. Top, BaP1 conformer 1 undergoes a conformational change after
about 20 ns. The 2D-rmsd plot shows two stable conformations. The first
is sampled from about 7 to 20 ns, and the second from 20 to 30 ns. Within
these simulation times, the conformations stay stable. Besides the flexibility
of residues 156-167, which is the main focus of this study, residues 59-70
rearrange. Presumably, this does not affect the former loop. Bottom,
Alignment of a snapshot after 15 ns (green) overlaid with a snapshot after
25 ns (pale green). The two loops that undergo the structural transition are
highlighted. The first loop lasts from residues 59 to 70, while the second
(residues 153-163) is in the protein-protein-interface area.
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Analyses of the flexibility of the complexes in the simulations
are performed with calculation of B factors. Plots for residue-
wise (mean B factor for every residue) B factors for all six
complexes are shown in Figure 4.
Despite small differences in intensity, the overall motions
are very similar. The only exception is the region from residue
156 to 175. A close up view (Figure 5) shows that two flexibility
groups can be observed.
The hemorrhagic active proteins (acutolysin-A and the two
conformers of BaP1) exhibit a significantly higher flexibility
in the first part of the loop (before the Met-turn; residues
156-163), while the inactives have much higher flexibility in
the loop region after the Met-turn (residue numbers 166-175).
Acutolysin-A has a peak of dynamics at the end of the loop at
Met163, the residues before have no significantly higher
flexibility than the inactives at the same positions. BaP1
conformer 1 is by far the most flexible example and hence
reaches the highest B factors. The whole loop area from Ser156
to Lys162 shows highly dynamic behavior. In contrast to
acutolysin-A, BaP1 conformer 2 shows its peak of flexibility
in the loop from residue 157 to 159.
Hemorrhagic inactive proteins (H2-proteinase and leucurol-
ysin-A with and without edo) show a different behavior. Slightly
above-average flexibility in the 156-165 region is observed,
but they have significantly lower B factors (about three times)
than the actives. However, a consistent picture is observed in
the loop area after the Met-turn from residue 168 to 175. In all
three cases, a double peak at almost the same residue numbers
Figure 4. Residue-wise B factor plots for all six complexes over the entire simulation (30 ns). While all six proteins show similar dynamic behavior in most
parts of the sequences, the protein interface region 156-175 provides remarkable differences. Figure 5 gives a close up view of this interesting region. Color
code: red, acutolysin-A; green, BaP1 conformer 1; blue, BaP1 conformer 2; yellow, H2-proteinase; turquoise, leucurolysin-A with edo; magenta, leucurolysin-A
without edo.
Figure 5. Detailed residue-wise B factor plot for the flexible loops (residues 156-175). While in the rest of the proteins a similar dynamic behavior is
found, a separation of hemorrhagic active and inactive proteins is found here. The actives undergo greater conformational changes in the region 156-163,
and the inactives are more flexible in the 167-175 part, respectively. The ability to bind the target proteins is likely to be related to the dynamics of this
loop. Color code: red, acutolysin-A; green, BaP1 conformer 1; blue, BaP1 conformer 2; yellow, H2-proteinase; turquoise, leucurolysin-A with edo; purple,
leucurolysin-A without edo; black, mean B factor over all residues and simulations. To illustrate the convergence of the results, the Supporting Information
provides the plot just for the last 15 ns and just for the backbone atoms in the last 15 ns.
J. AM. CHEM. SOC. 9 VOL. 132, NO. 30, 2010 10335
Specificity in Snake Venom Metalloproteases A R T I C L E S
is found. Residues 170 (in case of H2-proteinase residue 169)
and 172 are the most flexible amino acid side chains. The active
proteins do not show a similar behavior. They show almost no
dynamics with B factors far below average after the Met-turn
region.
Splitting the B factors into backbone and side chain contribu-
tions, the inactives show analogous composition of the overall
B factors in the 168-175 region. B factors calculated from the
side chain motions are twice as large as the backbone atom
ones. However, backbone B factors are by far (a factor of 5-7)
higher than those for hemorrhagic active proteins. The same
applies to the side chain atoms. The actives have their highest
flexibility in the area before the Met-turn (residues 156-165),
where the B factor composition is not homogeneous. While
acutolysin-A and conformer 2 of BaP1 behave similarly to the
inactives in the region after the Met-turn (a ratio of 2:1 of side
chain and backbone B factors), BaP1 conformer 1 shows a much
larger backbone contribution (almost 1:1 ratio). Thus, the
backbone significantly contributes to the dynamics and flexibility
differences between hemorrhagic actives and inactives.
Consequently, the trajectories were clustered and representa-
tive structures were calculated for every cluster in each
trajectory. Hence, every single structure represents a cluster of
many snapshots, which are related to the representative one
(Figure 6).
Except for residues 156-175, all parts of the proteins stay
in perfect alignment (the only exception is the above-mentioned
second mobile loop in BaP1 conformer 1). Hence, the clustering
was done on residues 156-175 and therefore the structural
changes of the presumed protein-protein interface are inves-
tigated. Flexibility, as represented by the B-factors, is not due
to a higher local fluctuation, but rather a slow flip of the
backbone. This results in a fan-like shaped conformational
ensemble as shown in Figure 6. Although, hemorrhagic active
and inactive proteins show this behavior, they differ in the region
of its occurrence. While in case of the actives the already as
flexible identified loop (156-163) before the Met-turn is
confirmed flexible, the inactives stay rigid here. However, after
the Met-turn (167-175) the actives exhibit a rigid behavior and
the inactives show the fan-shape conformations.
Discussion
We present MD simulations of SVMPs, proteins that have
to bind membrane proteins to induce their hemorrhagic effect.
However, these enzymes have drastically differing hemorrhagic
activity, although the proteins possess a high sequential and
structural homology. The first hint that dynamics may play a
crucial role for this protein-protein interaction site already
emerged from the X-ray structure of BaP1.72 Parts of a loop
(residues 159-163) were found to exist in two clearly distin-
guishable conformations.
Consequently, we suggest that this enables this area to be
the multispecific protein-protein interface, which allows SVMPs
to induce hemorrhage. To test this assumption, we have set up
six simulations of four SVMPs. Under consistent experimental
conditions, two of them are hemorrhagic active, while the other
two are not. Our simulations show converged behavior as
evidenced by rather stationary dynamics. Only the surface area,
composed of two loops (residues 156-165 and 167-175),
exhibits a remarkable movement pattern. Both loops can be
observed in many different conformations. This is not restricted
to side chain atoms, but the whole backbone flips. The large
motions are highly noteworthy, because residue 157 and residue
159 are cross-linked disulfide cysteines usually implying a
higher rigidity.
Even more remarkably, we find a separation of hemorrhagic
active and inactive proteins. While the actives exhibit the
enhanced motions in the first loop (residues 156-165), the
inactives have a dynamic loop at residues 167-175. This
supports our premise that this particular region is responsible
for the different hemorrhagic potency and, thus, the ability to
bind the target proteins in the BM.
According to the “conformational selection” theory, we
suppose that a sufficient adaptability of the loop 156-165 is a
prerequisite for the docking of different target proteins. In this
model, the main task of the loop seems to be providing the
“correct” conformation for every binding partner. Therefore, the
loop 156-165 may control the target specificity of SVMPs.
Figure 6. Alignment of the X-ray structure and five representative structural clusters observed during the simulations. Residues 156-175 are highlighted.
For the hemorrhagic active proteins (first line), the right part of the highlighted loops (residues 156-163) performs significant conformational changes, while
the left part (residues 167-175) keeps its conformation during the entire 30 ns of MD simulation. For the inactive proteins (second line), the dynamics of
the loops are the opposite way around.
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Further, we surmise that the location of the interface introduces
the possibility to induce conformational changes in the pro-
teolytic binding site (Figure 7).
The dynamic interactions over several hydrogen bonds allow
direct conformational communication. Hence, if the loops
become rigid upon binding, then propagation into the binding
site may be the next step. However, only an experimentally
determined structure (or several of them) of the protein-protein
complex could confirm this assumption. To illustrate the
alteration of the binding site dimensions during the simulations,
the Supporting Information provides distance vs simulation time
plots of relevant distances for all six simulations. Again, a
different behavior for hemorrhagic active and inactive proteins
is found.
The fact that the whole backbone moves is of great interest
for the field of protein engineering. Most current protein design
methods assume a fixed backbone. In consideration of this, the
sequence is changed in order to generate new properties of the
target protein. However, in the case of multispecificity of
SVMPs, this would not lead to success. From our results, we
argue that not sequence deviations in the 157-175 region but
a considerably enhanced flexibility resulting from these small
sequence deviations alter the ability to bind the target proteins.
Consequently we surmise that backbone flexibility could be also
essential for other protein-protein interactions and their
specificity.
Conclusions
SVMPs have different abilities to bind target proteins. Until
now, no explanation of the different hemorrhagic potential,
which is related to binding ability, was found. We suggest that
this is a problem completely related to dynamics. Despite a high
sequential homology, the loop region 156-175 shows totally
different flexibility for actives and inactives. This area is
suspected to be the multispecific protein-protein interface.
In contrast to the assumptions in most current protein design
approaches, the specificity of the interface is connected with
large backbone shifts. A fan-shaped conformational ensemble
for the protein-protein interface region is found in our
simulations. A certain combination of flexibility (residues
156-165) and rigidity of the neighboring loop (residues
167-175) provides an appropriate association domain for every
target protein. Hemorrhagic inactive proteins do not offer this
particular flexibility. Hence, a separation in context of activity
can be achieved by B factor calculation.
A deeper understanding of the functionality of the mechanism
of hemorrhage is fundamental to create treatment possibilities
for the victims of snake bites. However, SVMPs are even more
interesting, due to their high structural analogy to human proteins
like ADAMs (a disintegrin and metalloproteinase domain
containing enzymes) and MMPs (matrix metalloproteinases).
Finally, we emphatically recommend considering backbone
flexibility as a source of multispecificity in protein-protein
interfaces. It is likely that the mechanism suggested in this study
is not limited to SVMPs and their substrates but can be
transferred to other protein-protein interfaces.
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Figure 7. The loop that is flexible in the actives is shown in red (residues
156-165), whereas the one that is flexible in the inactives is shown in
blue (residues 167-175). The gray sphere represents the zinc ion, which is
close to the loops. The structure of BaP1 (green; pdb code 2W15) and the
ligand (cyan) in the binding site illustrate the close vicinity. Dynamics of
the two loops and a rigidization of them upon target protein binding are
expected to influence the conformation of the proteolytic binding site.
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